DrugPatentWatch Database Preview
Neurelis Inc Company Profile
» See Plans and Pricing
What is the competitive landscape for NEURELIS INC, and when can generic versions of NEURELIS INC drugs launch?
NEURELIS INC has one approved drug.
There are five US patents protecting NEURELIS INC drugs.
There are sixty-two patent family members on NEURELIS INC drugs in eighteen countries.
Drugs and US Patents for Neurelis Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-001 | Jan 10, 2020 | RX | Yes | No | 9,763,876 | Start Trial | Y | Start Trial | |||
Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-002 | Jan 10, 2020 | RX | Yes | No | 9,642,913 | Start Trial | Y | Start Trial | |||
Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-003 | Jan 10, 2020 | RX | Yes | Yes | 9,763,876 | Start Trial | Y | Start Trial | |||
Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-001 | Jan 10, 2020 | RX | Yes | No | 10,265,402 | Start Trial | Y | Start Trial | |||
Neurelis Inc | VALTOCO | diazepam | SPRAY;NASAL | 211635-003 | Jan 10, 2020 | RX | Yes | Yes | Start Trial | Start Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Neurelis Inc Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 2720699 | Start Trial |
Spain | 2683902 | Start Trial |
Hong Kong | 1164059 | Start Trial |
European Patent Office | 3415139 | Start Trial |
Brazil | 112020015646 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.